Perinatal, metabolic, and reproductive features in PPARG-related lipodystrophy

Objective: The adipogenic PPARG-encoded PPAR gamma nuclear receptor also displays essential placental functions. We evaluated the metabolic, reproductive, and perinatal features of patients with PPARG-related lipodystrophy. Methods: Current and retrospective data were collected in patients referred to a National Rare Diseases Reference Centre. Results: 26 patients from 15 unrelated families were studied (18 women, median age 43 years). They carried monoallelic PPARG variants except a homozygous patient with congenital generalized lipodystrophy. Among heterozygous patients aged 16 or more (n = 24), 92% had diabetes, 96% partial lipodystrophy (median age at diagnosis 24 and 37 years), 78% hypertriglyceridaemia, 71% liver steatosis, and 58% hypertension. The mean BMI was 26 +/- 5.0 kg/m(2). Women (n = 16) were frequently affected by acute pancreatitis (n = 6) and/or polycystic ovary syndrome (n = 12). Eleven women obtained one or several pregnancies, all complicated by diabetes (n = 8), hypertension (n = 4), and/or hypertriglyceridaemia (n = 10). We analysed perinatal data of patients according to the presence (n = 8) or absence (n = 9) of a maternal dysmetabolic environment. The median gestational age at birth was low in both groups (37 and 36 weeks of amenorrhea, respectively). As expected, the birth weight was higher in patients exposed to a foetal dysmetabolic environment of maternal origin. In contrast, 85.7% of non-exposed patients, in whom the variant is, or is very likely to be, paternally-inherited, were small for gestational age. Conclusions: Lipodystrophy-related PPARG variants induce early metabolic complications. Our results suggest that placental expression of PPARG pathogenic variants carried by affected foetuses could impair prenatal growth and parturition. This justifies careful pregnancy monitoring in affected families.

Automated summary

This study evaluates the role of the adipogenic PPARG-encoded PPAR gamma nuclear receptor in metabolism, reproduction, and perinatal features in patients with PPARG-related lipodystrophy. The results show that most patients suffer from metabolic complications such as diabetes, partial lipodystrophy, hypertriglyceridemia, liver steatosis, and hypertension, as well as reproductive issues such as acute pancreatitis and polycystic ovary syndrome. Moreover, the presence of PPARG variants in affected foetuses could impair prenatal growth and parturition.